QBX (FORMERLY KNOWN AS PHI-5, K041059)- zinc and rubidium cream 
Biocellerex, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

INDICATIONS:

1-Label_QBX

QBX (FORMERLY KNOWN AS PHI-5, K041059) 
rubidium chloride, zinc chloride cream
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:69801-102
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ZINC (UNII: J41CSQ7QDS) (ZINC - UNII:J41CSQ7QDS) ZINC0.006 g  in 100 mL
RUBIDIUM (UNII: MLT4718TJW) (RUBIDIUM - UNII:MLT4718TJW) RUBIDIUM0.17 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
POTASSIUM CITRATE (UNII: EE90ONI6FF)  
CALCIUM CHLORIDE (UNII: M4I0D6VV5M)  
BENZOIC ACID (UNII: 8SKN0B0MIM)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69801-102-1110 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other07/14/201501/05/2016
Labeler - Biocellerex, Inc. (079715783)

Revised: 1/2016
Document Id: c7f815dd-d488-476c-87a1-d4d5fbc0c67b
Set id: 0f713b79-02f4-4036-a67c-80e048f76ebe
Version: 3
Effective Time: 20160109
 
Biocellerex, Inc.